Clin2
NCT06765265Likely a fitRecruiting

Comparing two statins' effect on vitamin D after heart attack

Acute Coronary Syndromes

Treatments studied

Part of Heart & circulation clinical trials.

This study compares two common statins (atorvastatin and rosuvastatin) to see how they affect vitamin D levels in people who have recently had a heart attack or unstable angina. It may help doctors choose the best statin for your heart and vitamin D health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
152 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have been diagnosed with acute coronary syndrome (a serious heart condition like a heart attack or unstable angina).
  • Your vitamin D level is between 30 and 70 ng/mL (doctor can check with a blood test).
  • You are not pregnant or breastfeeding.
  • You are not allergic to statin drugs (like atorvastatin or rosuvastatin).
  • You do not have high or low calcium levels, underactive thyroid, or abnormal liver/kidney function.
  • You have not used vitamin D pills, cholesterol drugs, weight-loss drugs, or corticosteroids in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07508254Not yet recruiting· Phase 4
Comparing strong vs very strong cholesterol drugs after a heart attack

This trial tests whether adding two extra medicines to a common cholesterol-lowering statin lowers LDL ('bad') cholesterol more effectively in people recently hospitalized for a heart attack or unstable chest pain.

Lahore, Punjab Province
NCT04499859Recruiting· Phase 4
Low-dose cholesterol medicines versus high-dose after heart attack

This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.

Bucheon-si, Gyeonggido
NCT06767774Recruiting· Phase 4
Comparing two cholesterol treatments for heart patients

This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.

Seoul
NCT04347434Recruiting· Phase 4
Long-term cholesterol medicines after heart attack

This trial studies how well long-term cholesterol-lowering treatment works in people who recently had a heart attack (STEMI or NSTEMI). It may help your care team understand which patients benefit most and how treatment should be continued safely.

Penza
NCT07389304Not yet recruiting· Phase 1
Heart effects of common cholesterol drugs in healthy people

This trial tests how two common cholesterol-lowering drugs (statins) affect heart health in healthy volunteers. It helps researchers understand if these drugs have any effects on heart rate, blood pressure, or heart rhythm in people without existing health problems.

Dīr, Khyber Pakhtunkhwa
NCT06603363Recruiting
Statin effects on heart artery plaques seen on CT scans

This trial studies how short-term statin therapy changes plaque buildup in heart arteries. It uses CT scans to see if statins can make plaques more stable and reduce heart risks.

Budapest, Budapest

Hear when a new Acute Coronary Syndromes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.